Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-Current Debt (2018 - 2025)

TransMedics (TMDX) has 8 years of Non-Current Debt data on record, last reported at $49.6 million in Q4 2025.

  • For Q4 2025, Non-Current Debt fell 16.48% year-over-year to $49.6 million; the TTM value through Dec 2025 reached $49.6 million, down 16.48%, while the annual FY2025 figure was $49.6 million, 16.48% down from the prior year.
  • Non-Current Debt reached $49.6 million in Q4 2025 per TMDX's latest filing, down from $54.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $59.5 million in Q2 2025 and bottomed at $34.8 million in Q1 2021.
  • Average Non-Current Debt over 5 years is $51.2 million, with a median of $58.7 million recorded in 2022.
  • Peak YoY movement for Non-Current Debt: surged 66.98% in 2022, then fell 16.48% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $35.2 million in 2021, then surged by 66.76% to $58.7 million in 2022, then rose by 0.63% to $59.1 million in 2023, then rose by 0.52% to $59.4 million in 2024, then decreased by 16.48% to $49.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $49.6 million in Q4 2025, $54.6 million in Q3 2025, and $59.5 million in Q2 2025.